Understand how PIQRAY works to treat HR+, HER2- mBC with a PIK3CA mutation.
PIQRAY tablets is a once-daily oral tablet that is prescribed with fulvestrant. Fulvestrant is an injectable hormone therapy administered by your health care provider. It is important to always follow your doctor's directions on how to take PIQRAY.
The Support You Need
Get all the support you need as you begin treatment with PIQRAY by signing up for our Patient Navigator Program. Our experienced team is specially trained to answer questions about dosage, help navigate insurance issues, and more.
When starting a new treatment, you may have questions and concerns. This onboarding video can provide some important, useful information to help you better understand treatment with PIQRAY. If you have any further questions, talk to your doctor.
The recommended dose of PIQRAY is 300 mg (two 150-mg film-coated tablets) taken orally, once daily, with food. When given with PIQRAY, the recommended dose of fulvestrant is 500 mg administered as an injection by your doctor on days 1, 15, and 29, and once monthly thereafter. Ask your doctor for additional dosing information for fulvestrant.
The PIQRAY blister pack is designed to help you stay on track with treatment. The pack is color-coded to help you take the right dose on the right day.